Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,523,205
-$430,860 QoQ
Shares Held
17,810
-12.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
#1,693
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abacus Wealth Partners, LLC holds $15,909,181 across 13 Drug Manufacturers - General names. JNJ ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
17,810 | $4,523,205 | |
| 2 | ABBV |
AbbVie Inc.
|
8,029 | $2,020,417 | |
| 3 | LLY |
ELI LILLY & Co
|
1,508 | $1,808,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,511 | $1,479,163 | |
| 5 | NVS |
Novartis AG
|
8,613 | $1,349,829 | |
| 6 | BIIB |
Biogen Inc.
|
4,808 | $1,038,816 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,107 | $771,558 | |
| 8 | NVO |
Novo Nordisk A S
|
15,818 | $758,314 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,523,205 | 17,810 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,954,065 | 20,267 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,064,084 | 19,638 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $947,125 | 5,108 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $699,595 | 4,580 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $837,492 | 5,050 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $840,531 | 5,812 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,138,147 | 7,023 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $750,970 | 5,138 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $832,712 | 5,264 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $720,847 | 4,599 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $700,252 | 4,496 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $476,532 | 2,879 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $461,900 | 2,980 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $254,376 | 1,440 | Shares | Sole | 2023-06-01 | |
| 2022-09-30 | $304,829 | 1,866 | Shares | Sole | 2023-05-31 | |
| 2022-06-30 | $307,269 | 1,731 | Shares | Sole | 2023-05-31 | |
| 2022-03-31 | $330,356 | 1,864 | Shares | Sole | 2023-05-31 | |
| 2021-12-31 | $514,920 | 3,010 | Shares | Sole | 2023-05-31 | |
| 2021-09-30 | $525,359 | 3,253 | Shares | Sole | 2023-05-31 | |
| 2021-06-30 | $600,971 | 3,648 | Shares | Sole | 2023-05-31 | |
| 2021-03-31 | $606,780 | 3,692 | Shares | Sole | 2023-05-31 | |
| 2020-12-31 | $449,005 | 2,853 | Shares | Sole | 2023-05-31 | |
| No filing history on record for this holder in this stock. | ||||||